# Impact of Cytokine Genes on TMD and QoL in Construction Workers

**Authors:** André Miquilussi Moreira, Samantha Schaffer Pugsley Baratto, Débora Cristina Cardozo Bueno, Gisele Maria Correr, Cristiano Miranda de Araujo, Christian Kirschneck, Bianca Cavalcante-Leão, Erika Calvano Küchler, Flares Baratto-Filho, Michelle Nascimento Megerx

PMC · DOI: 10.1590/0103-644020256581 · Brazilian Dental Journal · 2026-01-09

## TL;DR

This study found that genetic variations in interleukin genes affect the quality of life in construction workers with temporomandibular disorders.

## Contribution

The study links specific interleukin gene polymorphisms to oral health-related quality of life in TMD patients.

## Key findings

- Heterozygous AG in IL1B rs1143629 increased physical pain and disability in TMD patients.
- Homozygous CC in IL6 rs1800796 was linked to higher handicap scores in TMD individuals.
- Genetic polymorphisms in IL1B and IL6 are associated with OHRQoL in TMD patients.

## Abstract

Temporomandibular disorders (TMD) include changes related to the presence of orofacial pain, limited mouth opening, and inflammatory issues. These inflammatory issues are related to interleukins, which are inflammatory mediators. Thus, the presence of genetic polymorphisms in genes that encode interleukins could impact TMD. Therefore, this cross-sectional study aimed to assess the impact of genetic polymorphisms in the genes encoding interleukins on the oral health-related quality of life (OHRQoL) of individuals with TMD. A total of 230 male construction workers were evaluated regarding the presence of TMD with or without pain, as well as changes in the temporomandibular joint (TMJ), using the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). OHRQoL was assessed using the 14-item Oral Health Impact Profile (OHIP-14). DNA extracted from saliva was used to evaluate the genetic polymorphisms in IL1B (rs1143627 and rs1143629) and IL6 (rs1800795 and rs1800796) using real-time polymerase chain reaction. Student's t-test or ANOVA was used for statistical analysis (alpha=5%). An association between OHIP-14 and TMD was observed (p<0.05). Individuals’ heterozygous AG in rs1143629 showed increased values in domains 2 (physical pain) and 4 (physical disability) compared to AA homozygotes (p=0.035; p=0.042, respectively). Individuals homozygous for the C allele at rs1800796 demonstrated higher values in domain 7 (handicap) compared to heterozygous CG and homozygous GG individuals (p=0.007). In conclusion, our study supported the hypothesis that TMD and genetic polymorphisms associated with inflammatory disorders are associated with OHRQoL

## Linked entities

- **Genes:** IL1B (interleukin 1 beta) [NCBI Gene 3553], IL6 (interleukin 6) [NCBI Gene 3569]
- **Diseases:** TMD (MONDO:0005473)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}
- **Diseases:** handicap (MESH:D009422), RDC (MESH:C535684), inflammatory (MESH:D007249), pain (MESH:D010146), TMD (MESH:D013705), physical disability (MESH:D059445), orofacial pain (MESH:D005157)
- **Mutations:** rs1143629, rs1800795, rs1800796, rs1143627

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12788404/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12788404/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12788404/full.md

---
Source: https://tomesphere.com/paper/PMC12788404